BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer. Cancers (Basel) 2020;12:E2519. [PMID: 32899818 DOI: 10.3390/cancers12092519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Koc MA, Asmellash S, Norman P, Rightmyer S, Roder J, Georgantas RW 3rd, Roder H. Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular Diagnostics. Molecules 2022;27:997. [PMID: 35164262 DOI: 10.3390/molecules27030997] [Reference Citation Analysis]
2 Schneider DJ, Lynch SA, Gelinas AD, Ostroff RM, Rohloff JC, Williams P, Janjic N, Drolet DW. SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics. RNA Therapeutics 2022. [DOI: 10.1016/b978-0-12-821595-1.00007-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Roder J, Maguire L, Georgantas R 3rd, Roder H. Explaining multivariate molecular diagnostic tests via Shapley values. BMC Med Inform Decis Mak 2021;21:211. [PMID: 34238309 DOI: 10.1186/s12911-021-01569-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]